Safilo Group S.p.A. (BIT:SFL)
1.589
-0.010 (-0.63%)
May 28, 2026, 4:52 PM CET
Safilo Group Employees
As of December 31, 2025, Safilo Group had 3,400 total employees, including 3,156 full-time and 244 part-time employees. The number of employees decreased by 245 or -6.72% compared to the previous year.
Employees
3,400
Change
-245
Growth
-6.72%
Revenue / Employee
€299,994
Profits / Employee
€14,838
Market Cap
663.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 3,400 | -245 | -6.72% | 3,156 | 244 |
| Jun 30, 2025 | 3,449 | - | - | 3,449 | 0 |
| Dec 31, 2024 | 3,645 | -183 | -4.78% | 3,352 | 293 |
| Dec 31, 2023 | 3,828 | -614 | -13.82% | 3,828 | 0 |
| Dec 31, 2022 | 4,442 | -103 | -2.27% | 4,442 | 0 |
| Dec 31, 2021 | 4,545 | -670 | -12.85% | 4,545 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amplifon | 15,078 |
| GPI S.p.A. | 7,834 |
| Recordati Industria Chimica e Farmaceutica | 4,693 |
| DiaSorin | 3,272 |
| Garofalo Health Care | 2,714 |
| EL.En. | 1,412 |
| Svas Biosana | 348 |
| Talea Group | 240 |
Safilo Group News
- 20 days ago - Safilo Group Earnings Call Transcript: Q1 2026 - Transcripts
- 20 days ago - Safilo Group Earnings release: Q1 2026 - Filings
- 20 days ago - Safilo Group Slides: Q1 2026 - Filings
- 2 months ago - Safilo Group Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Safilo Group Annual report: Q4 2025 - Filings
- 2 months ago - Safilo Group Earnings release: Q4 2025 - Filings
- 2 months ago - Safilo Group Slides: Q4 2025 - Filings
- 7 months ago - Safilo Group Earnings Call Transcript: Q3 2025 - Transcripts